Wall Street Analysts Predict a 42.28% Upside in Elicio Therapeutics (ELTX): Here's What You Should Know

Shares of Elicio Therapeutics (ELTX) have gained 41.8% over the past four weeks to close the last trading session at $12.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.33 indicates a potential upside of 42.3%.The mean estimate comprises three short-term price targets with a standard deviation of $0.58. While the lowest estimate of $17.00 indicates a 39.6% increase from ...